Biogen and Sage Therapeutics hold a joint investor webcast to discuss the planned commercialization approach and opportunity for their investigational product, Zuranolone, on December 6 at 8 am. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SAGE: